NEW YORK--(BUSINESS WIRE)--April 6, 2006--Neuro-Hitech Pharmaceuticals, Inc. (OTC BB: NHPI - News), a drug development company engaged in the development and commercialization of Huperzine A (HupA) and its analogues for Alzheimer's and other degenerative neurological disorders, today announced that it has appointed David Barrett as its Chief Financial Officer.
